Computational methods in drug design: modeling G protein-coupled receptor monomers, dimers, and oligomers
about
Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonistsComputational approaches for modeling GPCR dimerizationStructural biology of human cannabinoid receptor-2 helix 6 in membrane-mimetic environmentsLigand-binding architecture of human CB2 cannabinoid receptor: evidence for receptor subtype-specific binding motif and modeling GPCR activation.Apelin receptor homodimer-oligomers revealed by single-molecule imaging and novel G protein-dependent signaling.Requirements and ontology for a G protein-coupled receptor oligomerization knowledge base.Difference and Influence of Inactive and Active States of Cannabinoid Receptor Subtype CB2: From Conformation to Drug Discovery.Increasingly accurate dynamic molecular models of G-protein coupled receptor oligomers: Panacea or Pandora's box for novel drug discovery?A lipid pathway for ligand binding is necessary for a cannabinoid G protein-coupled receptorMethods used to study the oligomeric structure of G-protein-coupled receptors.Reflections on the theory of "silver bullet" octreotide tracers: implications for ligand-receptor interactions in the age of peptides, heterodimers, receptor mosaics, truncated receptors, and multifractal analysis.Solid-state NMR and molecular dynamics characterization of cannabinoid receptor-1 (CB1) helix 7 conformational plasticity in model membranesHetero-oligomerization of CCR2, CCR5, and CXCR4 and the protean effects of "selective" antagonists.Advances in the Development and Application of Computational Methodologies for Structural Modeling of G-Protein Coupled Receptors.Chromenopyrazole, a Versatile Cannabinoid Scaffold with in Vivo Activity in a Model of Multiple Sclerosis.Computational molecular biology approaches to ligand-target interactions.Prediction of the Human EP1 Receptor Binding Site by Homology Modeling and Molecular Dynamics SimulationMethods for the Development of In Silico GPCR Models.GPCR Conformations: Implications for Rational Drug Design.
P2860
Q24619974-6AC3F41A-770D-4776-99B2-E98B6E9E596BQ27001137-08B7D906-3569-4D20-932D-5E7215358AE2Q27655311-B52A0BE9-A056-4B48-B41E-6C7F6E49F3F0Q30373403-7FD2C44E-1E1F-4383-A662-8EAB4C50045AQ30835080-4EF9DDA6-3361-40D6-8942-35E61ADBD090Q33286209-357BA1D7-D7E9-4049-87D5-27149A538BABQ33574533-D69B6EE9-8B64-430D-8796-E77875520773Q33767121-73201AB7-5146-48F3-B035-414492DBE5CDQ33885350-44BD4947-42D6-481D-B49E-3203503BBA14Q34548734-E250C568-39EE-4496-B578-90BFC45A9A2DQ35650633-32B013E9-0588-419C-842D-778088BEFF9CQ37016808-AA403410-61ED-4DDB-8580-28A16CAF69DDQ37431503-D6344C3A-3DC7-4BA4-868D-614DDF1F9E30Q37578268-E80B9342-BB13-4918-80F0-2DECC953659CQ37659341-EF71E2A1-F65B-43CF-9529-F74F4E92D897Q37684817-EEBACF91-1822-48C5-A7AD-09C64E8D8571Q39281418-39B62298-610D-4D8D-A32D-9EF86CC836CDQ48020126-447EF331-7953-4B79-B868-EA5D8840ECC7Q55564362-D56FD4B0-1C9E-49F0-B4C4-D0AE38FA2FA5
P2860
Computational methods in drug design: modeling G protein-coupled receptor monomers, dimers, and oligomers
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Computational methods in drug ...... onomers, dimers, and oligomers
@ast
Computational methods in drug ...... onomers, dimers, and oligomers
@en
type
label
Computational methods in drug ...... onomers, dimers, and oligomers
@ast
Computational methods in drug ...... onomers, dimers, and oligomers
@en
prefLabel
Computational methods in drug ...... onomers, dimers, and oligomers
@ast
Computational methods in drug ...... onomers, dimers, and oligomers
@en
P2860
P921
P356
P1433
P1476
Computational methods in drug ...... onomers, dimers, and oligomers
@en
P2093
Patricia H Reggio
P2860
P2888
P304
P356
10.1007/BF02854903
P407
P577
2006-05-12T00:00:00Z